Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Revenue

In the year 2024, Niagen Bioscience had annual revenue of $99.60M with 19.18% growth. Niagen Bioscience had revenue of $29.13M in the quarter ending December 31, 2024, with 37.41% growth.

• Revenue (ttm): $99.60M
• Revenue Growth: +19.18%
• P/S Ratio: 4.98
• Revenue / Employee: $957,663
• Employees: 104
• Market Cap: 530.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.